Surgery is and Remains the Gold Standard for Limb-Threatening Ischemia

Similar documents
Stratifying Management Options for Patients with Critical Limb Ischemia: When Should Open Surgery Be the Initial Option for CLI?

John E. Campbell, MD Assistant Professor of Surgery and Medicine Department of Vascular Surgery West Virginia University, Charleston Division

Maximally Invasive Vascular Surgery for the Treatment of Critical Limb Ischemia

Case Discussion. Disclosures. Critical Limb Ischemia: A Selective Approach to Revascularization Works Best 4/28/2012. None. 58 yo M, DM, CAD, HTN

Disclosures. Talking Points. An initial strategy of open bypass is better for some CLI patients, and we can define who they are

The present status of selfexpanding. for CLI: Why and when to use. Sean P Lyden MD Cleveland Clinic Cleveland, Ohio

LIMB SALVAGE IN THE DIABETIC PATIENT

Limb Salvage in Diabetic Ischemic Foot. Kritaya Kritayakirana, MD, FACS Assistant Professor Chulalongkorn University April 30, 2017

Endovascular Should Be Considered First Line Therapy

Surgical Options for revascularisation P E T E R S U B R A M A N I A M

Interventional Treatment First for CLI

Peripheral Vascular Disease

Imaging Strategy For Claudication

PAD and CRITICAL LIMB ISCHEMIA: EVALUATION AND TREATMENT 2014

Disclosures. Objectives. Bypass vs. Endo for SFA Disease: Reaching Consensus on a Rational Approach. Christopher D. Owens, MD 4/23/2009

Endovascular Is The Way To Go: Revascularize As Many Vessels As You Can

Global Vascular Guideline on the Management of Chronic Limb Threatening Ischemia -a new foundation for evidence-based care

Disclosures. In-Stent Restenosis: The Tail IS Wagging the Dog 4/15/2016. Restenosis: The Continuing Challenge for Peripheral Vascular Intervention

Practical Point in Diabetic Foot Care 3-4 July 2017

Intercepting PAD. Playbook for Cardiovascular Care 2018 February 24, Jonathan D Woody, MD, FACS. University Surgical Vascular

PATIENT SPECIFIC STRATEGIES IN CRITICAL LIMB ISCHEMIA. Dr. Manar Trab Consultant Vascular Surgeon European Vascular Clinic DMCC Dubai, UAE

9/7/2018. Disclosures. CV and Limb Events in PAD. Challenges to Revascularization. Challenges. Answering the Challenge

Peripheral arterial disease for primary care Ed Aboian, MD

Practical Point in Holistic Diabetic Foot Care 3 March 2016

Olive registry: 3-years outcome of BTK intervention in Japan. Osamu Iida, MD Kansai Rosai Hospital Amagasaki, Hyogo, Japan

Critical Limb Ischemia: Diagnosis and Current Management

Recommendations for Follow-up After Vascular Surgery Arterial Procedures SVS Practice Guidelines

BEST-CLI Trial Study Concept and Current Status

Managing Conditions Resulting from Untreated Cardiometabolic Syndrome

Lower Extremity Peripheral Arterial Disease: Less is Sometimes More. Spence M Taylor, M.D.

Pedal Bypass With Deep Venous Arterialization:

Disclosures. Critical Limb Ischemia. Vascular Testing in the CLI Patient. Vascular Testing in Critical Limb Ischemia UCSF Vascular Symposium

Step by step Hybrid procedures in peripheral obstructive disease. Holger Staab, MD University Hospital Leipzig, Germany Clinic for Vascular Surgery

GLOBAL VASCULAR GUIDELINES: A NEW PATHWAY FOR LIMB SALVAGE

PAD Characterization Within A Healthcare System" RAPID Face-to-Face Meeting Schuyler Jones, MD September 14, 2016

Distal By-Pass procedures can reduce limb loss

NCVH. What's New on the Vascular Horizons? Craig M. Walker, MD, FACC, FACP. New Cardiovascular Horizons

Hybrid Procedures for Peripheral Obstructive Disease - Step by Step -

Popliteal Aneurysm: When is surgical therapy indicated? PROF. GRZEGORZ OSZKINIS

Easy. Not so Easy. Risk Assessment in the CLI Patient: Who is Likely to Benefit from Revascularization and Who is Not? 4/28/2012

SPINACH Making Limb Salvage Salad from Spinach alone

Diagnosis and Endovascular Treatment of Critical Limb Ischemia: What You Need to Know S. Jay Mathews, MD, MS, FACC

Intervention for Lower Extremity PAD: When, why and what?! Robert F Cuff, MD FACS RVT RPVI

Specificities for infrapopliteal stents

Amputation as a Last Resort A Multidisciplinary Approach to Limb Salvage

Lower Extremity Peripheral Arterial Disease: Its All About the Pulse. Spence M Taylor, M.D.

Garland Green, MD Interventional Cardiologist. Impact of PAD: Prevalence, Risk Factors, Testing, and Medical Management

Peripheral Arterial Disease: A Practical Approach

Critical Limb Ischemia A Collaborative Approach to Patient Care. Christopher LeSar, MD Vascular Institute of Chattanooga July 28, 2017

BC Vascular Day. Contents. November 3, Abdominal Aortic Aneurysm 2 3. Peripheral Arterial Disease 4 6. Deep Venous Thrombosis 7 8

Registry Assessment of Peripheral Interventional Devices (RAPID)

V.A. is a 62-year-old male who presents in referral

Comparison Of Primary Long Stenting Versus Primary Short Stenting For Long Femoropopliteal Artery Disease (PARADE)

Perfusion Assessment in Chronic Wounds

Evidence-Based Optimal Treatment for SFA Disease

Current Vascular and Endovascular Management in Diabetic Vasculopathy

Ron Fairman, MD Vice-President of the Society for Vascular Surgery MedCAC 2015

The Final Triumph Of Endovascular Therapy In SFA Treatment

4/23/2009. Vein Bypass Remains the Gold Standard AND We Can Improve Outcomes. Lower Extremity Revascularization Options: Key Factors to Consider

National Clinical Conference 2018 Baltimore, MD

Guidelines for Management of Peripheral Arterial Disease

Peripheral Arterial Disease. Westley Smith MD Vascular Fellow

Clasificación WIFI: Finalmente hablaremos el mismo idioma! WIfI: Wound, Ischemia, foot Infection The SVS Threatened Limb Classification

Making the difference with Live Image Guidance

Disclosures. Tips and Tricks for Tibial Intervention. Tibial intervention overview

Clinical Approach to CLI and Related Diagnostics: What You Need to Know

RevIewS. Interventions for lower extremity peripheral artery disease

CLI Treatment Using Long and Scoring Balloons

The ZILVERPASS study a randomized study comparing ZILVER PTX stenting with Bypass in femoropopliteal lesions

Remote Endarterectomy Update

Global Peripheral Artery Disease Market: Trends & Opportunities ( ) February 2016

Disclosures. TASC, AHA, SVS: What s Happening with the Guidelines? How Are They Relevant? Purpose of Practice Guidelines

Role of ABI in Detecting and Quantifying Peripheral Arterial Disease

Endovascular and Hybrid Treatment of TASC C & D Aortoiliac Occlusive Disease

Current Status and Limitations in the Treatment of Femoropopliteal In-Stent Restenosis

RC 612B 3 December Richard L. Hallett, MD

Angiosome concept myth or truth? Does it make a real difference in real world cases?

Are DES and DEB worth the cost in BTK interventions?

Guidelines for Ultrasound Surveillance

Update on BEST-CLI Trial

Lower-Extremity Revascularization

3-year results of the OLIVE registry:

Peripheral Arterial Disease: the growing role of endovascular management

Introduction. Risk factors of PVD 5/8/2017

Endovascular treatment (EVT) has markedly advanced,

Critical limb ischaemia: an update for the generalist

Forget about the angiosome theories. Yann Gouëffic, MD, PhD Department of vascular surgery, institut du thorax, Nantes, France

SAFETY AND EFFECTIVENESS OF ENDOVASCULAR REVASCULARIZATION FOR PERIPHERAL ARTERIAL OCCLUSIONS

DCB in my practice: How the evidence influences my strategy. Yang-Jin Park

Boca Raton Regional Hospital Grand Rounds September 13, 2016

Acknowledgements. No tengo conflictos de interés que revelar. I have no conflicts of interest to disclose. Michael S. Conte. David G.

Larry Diaz, MD, FSCAI Mehdi H. Shishehbor, DO, FSCAI

The ZILVERPASS study a randomized study comparing ZILVER PTX stenting with Bypass in femoropopliteal lesions Preliminary report

Aortoiliac occlusive disease

John E. Campbell, MD. Assistant Professor of Surgery and Medicine Department of Vascular Surgery West Virginia University, Charleston Division

North American Society of Cardiovascular Imaging Annual Meeting, Baltimore MD, October 15-18, Tips and Tricks in Vascular Imaging

Peripheral Arterial Disease: Who has it and what to do about it?

Transcription:

Surgery is and Remains the Gold Standard for Limb-Threatening Ischemia Albeir Mousa, MD., FACS.,MPH., MBA Professor of Vascular and Endovascular Surgery West Virginia University

Disclosure None

What you will do with That?

Definition of Critical Limb Ischemia Rutherford 5 Inadequate blood flow to accommodate resting metabolic needs Will result in limb loss unless perfusion is improved Includes ischemic rest pain, nonhealing ischemic, and gangrene

Introduction Peripheral Artery Disease (PAD) is estimated to affect 8 to 10 million Americans Critical limb ischemia (CLI) is the most advanced form of PAD, it is associated with a high risk of cardiovascular events, including major limb loss, myocardial infarction, stroke, and death The likelihood of death has been reported to be as high as 20% within 6 months of CLI diagnosis and surpasses 50% at 5 years post diagnosis Criqui MH, Langer RD, Fronek A, et al. Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med. 1992;326:381 386. Hirsch AT, Hartman L, Town RJ, Virnig BA. National health care costs of peripheral arterial disease in the Medicare population. Vasc Med. 2008;13:209 215. doi: 10.1177/1358863X08089277.

Economic Impact A study analyzing Medicare data for 2001 $4.37 billion was spent on PAD-related treatment In total, PAD-related treatment accounted for approximately 13% of all Medicare Part A and B expenditures for the PAD-treated cohort, and 2.3% of all Medicare Part A and B annual spending Total Medicare expenditure in 2011 was 549.1 B Hirsch AT, Hartman L, Town RJ, Virnig BA. National health care costs of peripheral arterial disease in the Medicare population. Vasc Med. 2008;13:209 215. doi: 10.1177/1358863X08089277.

Chronic Lower Extremity Ischemia Classification Rutherford Category Clinical Description 0 Asymptomatic 1 Mild claudication 2 Moderate claudication 3 Severe claudication 4 Rest pain 5 Minor tissue loss/non-healing ulcer/focal gangrene 6 Major tissue loss or gangrene, extending above the transmetatarsal level (Adapted from Rutherford RB, Flanigan DP, et al. Suggested standards for reports dealing with lower extremity ischemia. J Vasc Surg 1986; 4:80 94.)

SVS Lower Extremity Threatened Limb Classification WIFI Index Wound: extent and depth Ischemia: perfusion/flow Foot Infection: presence and extent

Hemodynamics and Probability of Healing of a Diabetic Foot Ulcer- No Threshold Healing unlikely if toe pressure < 55 mmhg, Mills, JVS 2014

Options for Revascularization in CLI Endovascular Angioplasty Stent Atherectomy Lysis Open surgery Bypass with vein/artery Bypass with prosthetic graft Endarterectomy Non-operative Hyperbaric Rx Arterial compression SCS Optimal wound care

Gold Standard & Literature The BASIL (Bypass Versus Angioplasty in Severe Ischaemia of the Leg) trial, sponsored by the UK National Institute of Health Research Health Technology Assessment program, is the only randomized controlled trial (RCT) comparing open surgical bypass with endovascular therapy in patients with CLI due to infrainguinal disease Adam DJ, Beard JD, Cleveland T, et al. Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial. Lancet. 2005;366:1925 1934. doi: 10.1016/S0140-6736(05)67704-5. [PubMed] [Cross Ref]

BASIL Trial Study started in 1999 randomly assigned 452 patients from 27 centers reported an no difference in overall survival or amputation-free survival by intention-to-treat analysis between surgical bypass and endovascular therapy, with surgery being more expensive in the short term. However, post hoc analysis demonstrated that beyond 2 years, patients initially assigned to open bypass surgery had a significantly improved amputation-free survival (adjusted HR, 0.37; 95% CI, 0.17 0.77; P = 0.008) and reduced all-cause mortality (adjusted HR, 0.34; 95% CI, 0.17 0.71; P = 0.004) relative to angioplasty [6].

Patients presenting with severe limb ischemia due to infrainguinal disease and who are suitable for surgery and angioplasty, a bypass-surgery-first and a balloon-angioplasty-first strategy are associated with broadly similar outcomes in terms of amputation-free survival, and in the short-term, surgery is more expensive than angioplasty Take Home Point! Lancet 2005; 366:1925-34

Evidence based TASC II Guidelines (Only Anatomic!) Stratifies Rx of arterial occlusive disease, based on location (iliac and femoral) and extent of disease Increasingly ignored by Cardiologists, IR, and Vascular Surgeons Journal of Vascular Surgery January 2007

Debate at 2009 SVS VAM Should endovascular or open surgery be the initial therapy for TASC D disease of the infrapopliteal arteries? Strong arguments made by Meier supporting endovascular first approach, and Conte, supporting open first approach

Arguments For Endo First Procedures for CLI Better patient acceptance Lower initial morbidly and mortality with endo procedures Fewer wound complications More rapid return to activity in most patients Adequate improvement in perfusion with endo approach Limited life expectancy Better reimbursement per hour of work

Arguments for Open First Procedure for CLI Immediate complete revascularization Greater increase in blood flow to the limb More durable than endovascular Minimally invasive open techniques are no more invasive than endovascular Cost is less than with repeated endo procedures Long-term survival is the same

When Should Surgery Be Initial Therapy for CLI? Bypass Endovascular Patient selection

Journal of Vascular Surgery 2013 57, 8S-13SDOI: (10.1016/j.jvs.2012.05.114) Copyright 2013 Society for Vascular Surgery

Duplex arterial ultrasound Localizes disease Requires technical expertise Does not give complete physiologic information CT angiogram MR angiogram Catheter angiogram Imaging Key to Decision Making in CLI

0.3 mmol/kg 0.1 mmol /k 0.2 mmol /kg

Severe Calf disease: 7 ml Gd Habibi R, Krishnam MS, Lohan DG, Barkhordarian F, Jalili M, Saleh R, Ruehm S, Finn JP. High-Spatial-Resolution Lower Extremity Magnetic Resonance Angiography at 3.0 Tesla: A Contrast Dose Comparison Study. Radiology; 2008 Aug;248(2):680-92.

Your options? Lower-extremity bypass grafting with or without femoral endarterectomy, with or without adjunctive inflow (aortoiliac) treatment. The preferred graft conduit for infrainguinal bypass is autogenous saphenous vein followed by other autogenous venous conduits. Prosthetic or other nonautogenous conduits should be considered significantly inferior secondary choices for infrainguinal bypass in the CLI patient.

Open Intervention

Open Intervention

Situations Where Open Surgery Should Be the First Option (Opinion of Endovascular First VS) Anatomy Extensive disease of the common femoral artery which extends proximally under the inguinal ligament and distally into the profunda femoris artery Long segment occlusions of the infrapopliteal arteries (TASC D) Pathology Extrinsic compression of lower extremity arteries Physiology Extensive foot sepsis or gangrene Durability When combined with another bypass procedure

Situations Where Open Surgery Should Be the First Option (Anatomy) Extensive disease of the common femoral artery Stents ineffective Calcified vessels difficult to dilate Fracture with inguinal ligament compression Self-expanding have inadequate radial strength Atherectomy channel is too small Extensive disease of the infrapopliteal arteries Restenosis rate high with endo Difficult to establish durable pulsatile flow to the foot Lawrence, et al; Eur J Vasc Surg 2010

Femoral Endarterectomy Simple anatomic procedure Low risk Anesthesia with local or regional

Open Surgery : Inflow or outflow reconstruction is of primary importance for the long-term fate of the limb in CLI patients. A recent meta-analysis in patients with CLI undergoing infrainguinal bypass demonstrated 5-year primary patency, secondary patency, and limb salvage rates of 63%, 71%, and 78%, respectively Schanzer A, Hevelone N, Owens CD, et al. Technical factors affecting autogenous vein graft failure: observations from a large multicenter trial. J Vasc Surg. 2007;46:1180 1190. doi: 10.1016/j.jvs.2007.08.033.

Situations Where Open Surgery Should Be the First Option Pathology Extrinsic compression Popliteal entrapment Adventitial cystic disease Bony abnormalities (e.g. exostosis)

Popliteal Entrapment Posterior Approach to popliteal artery Division of aberrant muscle Release of artery or bypass

Situations Where Open Surgery Should Be the First Option (Durability) Patients undergoing free tissue transfer Need combination of durable bypass and tissue transfer Young patients with longer life expectancy Unwilling to undergo multiple procedures for the same pathology Infrapopliteal disease (extensive) in a young patient

Situations Where Open Surgery Should Be the First Option (Physiology) Diabetic patients with: Extensive tissue loss Forefoot sepsis Extensive forefoot gangrene Need immediate and maximum blood flow to foot- pulsatile blood flow

Degree of complete healing Type of Revascularization vs. Initial Size Wound Percent 100 90 80 70 60 50 40 30 20 10 0 * P = 0.01 86 82 71 50 31 25 Group A Group B Group C R Neville, et al Georgetown Diabetic Foot Center Bypass Endo

General Recommendations: CLI patients predicted to live more than 2 years, and with a useable vein, should usually have bypass surgery first. This is because the long term results of saphenous vein bypass surgery are good, the rate of balloon angioplasty failure is high, and the results of bypass surgery after failed balloon angioplasty are significantly worse than for bypass surgery. However, patients expected to live less than 2 years, and those without a useable vein, should usually have balloon angioplasty first as they will not survive to reap the longer term benefits of surgery and the results of prosthetic bypass surgery are poor [8]

My Recommendations: Tx decisions in CLI are individualized, based on life expectancy, functional status, anatomy of the arterial occlusive disease, and surgical risk. For infrainguinal disease, the available data suggest that surgical bypass with vein is the preferred therapy for CLI patients likely to survive 2 years, and for those with long segment occlusions or severe infrapopliteal disease who have and acceptable surgical risk

Conclusions In spite of current practice guidelines, most patients undergo an endo first approach for CLI Imaging with MRA and/or CTA is critical in determining the extent of disease CLI patients must be stratified; there are four situations in which an open first approach is preferable: Common femoral and extensive infra-popliteal disease Extrinsic compression Young patients who need durability Extensive tissue loss and sepsis (e.g. ischemic, septic diabetic foot)

Vascular Center of Excellence Thank You